SGD Pharma Beauty & Care Division Introduces Eclipse, an Eco-Designed, Refillable Packaging Solution

  • SGD Pharma

It’s no secret that the beauty industry is undergoing an eco-friendly make-over, and cosmetics brands are searching for high-quality, sustainable packaging solution. To fulfill the stringent demands of this market, SGD Pharma Beauty & Care has created Eclipse. 

We proudly announce the launch of our latest sustainable innovation, Eclipse, an eco-designed, refillable packaging solution for the Beauty industry. Innovative Twist & Lock system* joining two separate containers together, Eclipse offers consumers an effortless replacement and recycling experience.

As one of our stock molds, Eclipse is a bespoke full packaging solution including outer glass and plastic accessories: inner jar, gasket and cap. For brands, it helps to save significant time in development and accelerate the speed to market. Brands can further increase the sustainability characteristics by adding PCR content to the resin (up to 50% PCR PP) for the accessories.

We can create eye-catching looks for the glass using various sustainable decoration techniques. Our team of experts can also help brands to make customized packaging with Eclipse Twist & Lock mechanism*. 

Being eco-conscious has never looked so good!

See also

SGD Pharma launches industry first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology

Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products. The addition of 100 ml molded glass vials to the Sterinity platform is pioneering, with SGD Pharma being the first global molded glass manufacturing company to offer this size of solution in the RTU market.

SGD Pharma speeds up time to market with industry first Ready-to-Use Nest & Tub packaging solution for molded glass vials

Increased demand for parenteral drugs generated by the Covid-19 pandemic has resulted in additional pressures being placed on biopharmaceutical companies to accelerate their time-to-market. This new RTU primary and secondary packaging combination from SGD Pharma offers biopharmaceutical producers the flexibility they need to deliver innovative medicines to patients significantly faster.

SGD Pharma upgrades its Chinese plant toward an automated and improved production

SGD Pharma's Zhanjiang (China) plant produces 1.2 million Type II & III flint molded glass vials daily for the parenteral market and for health care beauty products. With a surface of ​​85,000m2, the plant included a glass furnace, 6 production lines, an ISO 8 clean room of 2000m2, a resorting room and a customization workshop. In early 2018, SGD Pharma invested 7 million Euros to improve the automation and the production, including the rebuilding of the furnace, to make the plant an exemplary production center.

  • Abigail Mackay
  • Product Info
  • English
  • Created 04 Nov 2022
  • Modified 08 Nov 2022
  • Hits 618